Healthgen Biotechnology(688765.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Healthgen Biotechnology
688765.SH
Wuhan Healthgen Biotechnology Corp. engages in the research and development of molecular pharmaceuticals in China. The company offers recombinant human serum albumin, proteins for cosmetics ingredients, and other recombinant proteins. It also provides recombinant growth factors, such as recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, recombinant human insulin-like growth factor-1 LR3, recombinant human vascular endothelial growth factor, recombinant human keratinocyte growth factor, recombinant human fibronectin, recombinant human a-1 antitrypsin, recombinant human lactoferrin, recombinant human epidermal growth factor, and recombinant human fibronectin.
1.576 T
688765.SHMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The Sci-Tech Innovation Board's Sci-Tech Growth Tier "welcomes" HeYuan Biotechnology, Xi'an YiCai, BeBetter, and others, all of which saw significant gains on their first day of listing

    The Sci-Tech Innovation Board's Sci-Tech Growth Tier "welcomes new arrivals," with HeYuan Biotechnology, Xi'an ESWIN, and BeBetter Med all experiencing significant gains on their first day of listing. As of the time of writing, Xi'an ESWIN has risen over 223%

    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%
    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%

    Four new stocks in the A-share market were listed for the first time, setting a new high for the number of listings in a single day this year

    Four new stocks were listed on the A-share market, setting a new high for the number of listings in a single day this year. Three unprofitable Sci-Tech Innovation Board companies opened significantly higher, with Xi'an ESWIN soaring 360%, BeBetter Med and Healthgen Biotechnology both rising over 100%; TaiKaiYing on the Beijing Stock Exchange increased by 154%

    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%
    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%

    The first batch of 3 new stocks from the Sci-Tech Innovation Growth Sector will be listed on October 28

    Healthgen Biotechnology, ESWIN, and BeBetter Med have all announced that they will be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 28, 2025. According to the "Self-Regulatory Guidelines for Listed Companies on the Sci-Tech Innovation Board No. 5 - Sci-Tech Growth Tier," companies on the Sci-Tech Innovation Board that are not profitable at the time of listing will be included in the Sci-Tech Growth Tier from the date of listing. As of the announcement date, all three new stocks have not yet turned a profit and will be included in the Sci-Tech Growth Tier from the date of listing

    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%
    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%

    On October 28th, Healthgen Biotechnology will be listed and will be included in the Sci-Tech Innovation Growth Tier from the date of listing

    On the evening of October 23rd, Healthgen Biotechnology announced that its stock will be listed on the Sci-Tech Innovation Board on October 28th. As of the announcement date, Healthgen Biotechnology has not yet turned a profit and will be included in the Sci-Tech Growth Tier from the date of listing

    Zhitong·
    SH
    688765
    -0.48%
    Zhitong·
    SH
    688765
    -0.48%

    New regulations for institutions participating in IPOs of unprofitable companies take effect — "high" lock-up = "high" allocation

    In June of this year, after the Science and Technology Innovation Board resumed the fifth set of standards for the listing of unprofitable companies, Healthgen Biotechnology, ESWIN, and BeBetter Med, three loss-making companies, were the first to enter the issuance stage. Recently, these three companies have successively disclosed the results of the lottery. As the first batch of companies to implement differentiated lock-up and allocation mechanisms in offline issuance, Class A1 and A2 institutional investors received more than 10 times the allocation ratio of Class B investors, but the lock-up period for the former two is longer, and the lock-up ratio is higher

    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%
    Zhitong·
    SH
    688759
    +10.10%
    SH
    688765
    -0.48%
    SH
    688783
    -1.11%
    © 2026 Longbridge｜Disclaimer